Nasobec Hayfever (Beclometasone Dipropionate)

Beclometasone dipropionate, the active ingredient in Nasobec Hayfever, is a corticosteroid presented as a nasal spray for endosinusial use. It is indicated for the treatment of allergic rhinitis, reducing inflammation and relieving symptoms such as sneezing, itching and nasal congestion.

GNH USA supplies Nasobec Hayfever as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Beclometasone dipropionate is a corticosteroid used to treat inflammatory conditions of the nasal passages.

Allergic rhinitis (hay fever): alleviates nasal inflammation and symptoms such as sneezing, itching and congestion. Seasonal allergic rhinitis: reduces seasonal nasal allergy symptoms and improves airflow. Perennial allergic rhinitis: controls year‑round nasal inflammation and associated discomfort.

Adverse reactions may occur with nasal administration of beclometasone dipropionate.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of the nasal passages - Epistaxis (nosebleeds) - Headache - Altered taste perception - Throat irritation

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Cataracts or glaucoma with prolonged use - Adrenal suppression - Opportunistic infections - Vision changes

Use Nasobec Hayfever only under medical supervision and follow prescribed duration.

Avoid prolonged continuous use: limit therapy to the period recommended by a healthcare professional. Do not use if active nasal infection is present: treat infection first. Caution in patients with glaucoma or ocular hypertension: monitor intra‑ocular pressure. Exercise caution in diabetic patients: systemic absorption may affect glucose control. Avoid contact with eyes: rinse thoroughly if accidental exposure occurs. Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Beclometasone dipropionate may interact with other medicines that affect corticosteroid activity or metabolism.

Major Interactions (Avoid): - Systemic corticosteroids: additive immunosuppressive effects may increase risk of systemic side effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise systemic exposure of beclometasone. - Live vaccines: immunosuppression could reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., fluconazole): may modestly increase corticosteroid levels. - Nasal decongestants (e.g., oxymetazoline): concurrent use may increase risk of nasal irritation.